Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic NAC for Cisplatin-induced Ototoxicity
NCT04291209Phase 2Unknown
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Feb 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in ototoxicity, sponsored by Sunnybrook Health Sciences Centre. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
ototoxicity
Beyond the preview
Go deeper on NCT04291209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04291209.